Editta Baldini

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Boldrini Laura; Alì Greta; Gisfredi Silvia; Ursino Silvia; Baldini Editta; Melfi Franca; Lucchi Marco; Comin Camilla E; Maddau Cristina; Tibaldi Carmelo; Camacci Tiziano; Servadio Adele; Mussi Alfredo; Fontanini Gabriella
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.
Capodanno Alessandra; Camerini Andrea; Orlandini Cinzia; Baldini Editta; Resta Maria Letizia; Bevilacqua Generoso; Collecchi Paola
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Editta Baldini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Boldrini Laura; Alì Greta; Gisfredi Silvia; Ursino Silvia; Baldini Editta; Melfi Franca; Lucchi Marco; Comin Camilla E; Maddau Cristina; Tibaldi Carmelo; Camacci Tiziano; Servadio Adele; Mussi Alfredo; Fontanini Gabriella
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.
Oncology reports 2009;22(4):683-91.
2009: Capodanno Alessandra; Camerini Andrea; Orlandini Cinzia; Baldini Editta; Resta Maria Letizia; Bevilacqua Generoso; Collecchi Paola
Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
Human pathology 2009;40(10):1408-17.
2008: Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):299-307.
2008: Schivazappa Chiara; Berto Patrizia; Baldini Editta; Barni Sandro; Dauria Giuliana; Cortesi Enrico
[Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies]
Recenti progressi in medicina 2008;99(1):27-31.
2007: Boldrini Laura; Gisfredi Silvia; Ursino Silvia; Camacci Tiziano; Baldini Editta; Melfi Franca; Fontanini Gabriella
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(12):1086-90.
2007: Gridelli Cesare; Ferrara Carmine; Guerriero Ciro; Palazzo Salvatore; Grasso Giuseppe; Pavese Ida; Satta Francesco; Bajetta Emilio; Cortinovis Diego; Barbieri Fausto; Gebbia Vittorio; Grossi Francesco; Novello Silvia; Baldini Editta; Gasparini Giampietro; Latino Walter; Durante Emilia; Giustini Lucio; Negrini Cristina
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(6):475-80.
2007: Lucchi M; Melfi F; Baldini E; Fontanini G; Boni G; Viti A; Mussi A
Sentinel lymph node mapping: detection of micrometastases by polymerase chain reaction in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5 Suppl):S37.
2007: Schivazappa Chiara; Baldini Editta; Cortesi Enrico; Dauria Giuliana; Roila Fausto; Berto Patrizia
[Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study]
Recenti progressi in medicina 2007;98(1):12-5.
2006: Baldini Editta; Camerini Andrea; Sgambato Alessandro; Prochilo Tiziana; Capodanno Alessandra; Pasqualetti Francesco; Orlandini Cinzia; Resta Letizia; Bevilacqua Generoso; Collecchi Paola
Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients.
Anticancer research 2006;26(6B):4415-21.
2006: Tibaldi C; Prochilo T; Russo F; Pennucci M C; Del Freo A; Innocenti F; Fabbri A; Falcone A; Conte P F; Baldini E
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study.
British journal of cancer 2006;94(9):1263-6.
2005: Venturini Marco; Del Mastro Lucia; Aitini Enrico; Baldini Editta; Caroti Cinzia; Contu Antonio; Testore Franco; Brema Fulvio; Pronzato Paolo; Cavazzini Giovanna; Sertoli Mario Roberto; Canavese Giuseppe; Rosso Riccardo; Bruzzi Paolo
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
Journal of the National Cancer Institute 2005;97(23):1724-33.
2005: Ardizzoni Andrea; Favaretto Adolfo; Boni Luca; Baldini Editta; Castiglioni Federico; Antonelli Paola; Pari Franca; Tibaldi Carmelo; Altieri Alfonso M; Barbera Sante; Cacciani Giancarlo; Raimondi Mario; Tixi Lucia; Stefani Micaela; Monfardini Silvio; Antilli Antonio; Rosso Riccardo; Paccagnella Adriano
Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):569-75.
2004: Baldini Editta; Gardin Giovanni; Evagelista Giuseppe; Prochilo Tiziana; Collecchi Paola; Lionetto Rita
Long-term results of combined-modality therapy for inflammatory breast carcinoma.
Clinical breast cancer 2004;5(5):358-63.
2004: Conte Pier Franco; Guarneri Valentina; Bruzzi Paolo; Prochilo Tiziana; Salvadori Barbara; Bolognesi Angelo; Aldrighetti Daniela; Venturini Marco; Rosso Riccardo; Mammoliti Serafina; Carnino Flavio; Giannessi Piergiorgio; Costantini Massimo; Moyano Alfredo; Baldini Editta;
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
Cancer 2004;101(4):704-12.
2004: Baldini Editta; Prochilo Tiziana
[The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence?]
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2004;3(4):S79-80.
2004: Baldini E; Prochilo T; Salvadori B; Bolognesi A; Aldrighetti D; Venturini M; Rosso R; Carnino F; Gallo L; Giannessi P; Conte P F; Orlandini C; Bruzzi P
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.
British journal of cancer 2004;91(1):45-9.
2003: Baldini Editta
No consensus on the optimal palliative radiotherapy regimen for people with inoperable non-small-cell lung cancer.
Cancer treatment reviews 2003;29(5):445-7.
2003: Baldini E; Gardin G; Giannessi P G; Evangelista G; Roncella M; Prochilo T; Collecchi P; Rosso R; Lionetto R; Bruzzi P; Mosca F; Conte P F
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):227-32.
2002: Baldini Editta; Ardizzoni Andrea; Prochilo Tiziana; Cafferata Maria A; Boni Luca; Tibaldi Carmelo
Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).
Cancer chemotherapy and pharmacology 2002;49 Suppl 1():S25-8.
2002: Danesi Romano; Innocenti Federico; Fogli Stefano; Gennari Alessandra; Baldini Editta; Di Paolo Antonello; Salvadori Barbara; Bocci Guido; Conte Pier Franco; Del Tacca Mario
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients.
British journal of clinical pharmacology 2002;53(5):508-18.
2001: Baldini E; Ardizzoni A; Prochilo T; Cafferata M A; Boni L; Tibaldi C; Neumaier C; Conte P F; Rosso R;
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).
British journal of cancer 2001;85(10):1452-5.
2001: Conte P F; Gennari A; Donati S; Salvadori B; Baldini E; Bengala C; Pazzagli I; Orlandini C; Danesi R; Fogli S; Del Tacca M
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study.
Breast cancer research and treatment 2001;68(2):171-9.
2001: Conte P; Gennari A; Guarneri V; Landucci E; Donati S; Salvadori B; Bengala C; Orlandini C; Baldini E
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials.
Oncology (Williston Park, N.Y.) 2001;15(5 Suppl 7):21-3.
2000: Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Seminars in oncology 2000;27(1 Suppl 1):28-32.
1999: Collecchi P; Passoni A; Rocchetta M; Gnesi E; Baldini E; Bevilacqua G
Cyclin-D1 expression in node-positive (N+) and node-negative (N-) infiltrating human mammary carcinomas.
International journal of cancer. Journal international du cancer 1999;84(2):139-44.
1998: Collecchi P; Baldini E; Giannessi P; Naccarato A G; Passoni A; Gardin G; Roncella M; Evangelista G; Bevilacqua G; Conte P F
Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers.
European journal of cancer (Oxford, England : 1990) 1998;34(11):1701-4.
1998: Baldini E; Tibaldi C; Ardizzoni A; Salvati F; Antilli A; Portalone L; Barbera S; Romano F; De Marinis F; Migliorino M R; Noseda M A; Borghini U; Crippa M; Ferrara G; Raimondi M; Fioretti M; Bandera M; Pennucci M C; Galeasso G; Cacciani G C; Lepidini G; Sunseri G; Lanfranco C; Rinaldi M; Rosso R
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
British journal of cancer 1998;77(12):2367-70.
1998: Baldini E; Tibaldi C; Chiavacci F; Di Lieto M; Fioretto L; Giallom-bardo A; Taviani R; Ghezzi P; Bolognini A; Conte P
Epirubicin/vinorelbine as first line therapy in metastatic breast cancer.
Breast cancer research and treatment 1998;49(2):129-34.
1997: Baldini E; Gardin G; Giannessi P; Brema F; Camorriano A; Carnino F; Naso C; Pastorino G; Pronzato P; Rosso R; Rubagotti A; Torretta G; Conte P F
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, Italy.
Tumori 1997;83(5):829-33.
1997: Conte P F; Baldini E; Gennari A; Michelotti A; Salvadori B; Tibaldi C; Danesi R; Innocenti F; Gentile A; Dell'Anna R; Biadi O; Mariani M; Del Tacca M
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2510-7.
1997: Baldini E; Tibaldi C; Lencioni M; Giannessi P; Evangelista G; Roncella M; Spinelli C; Meucci C; da Prato M; Conte P
Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients.
American journal of clinical oncology 1997;20(2):169-72.
1996: Conte P F; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi P G; Gentile A
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
Seminars in oncology 1996;23(6 Suppl 15):39-42.
1996: Baldini E; Tibaldi C; Pfanner E; Ricci S; Falcone A; Ceribelli A; Sarcina R; Comella G; Stampino C G; Conte P F
Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.
American journal of clinical oncology 1996;19(6):592-4.
1996: Michelotti A; Gennari A; Salvadori B; Tognoni A; Tibaldi C; Baldini E; Conte P F
Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):857-60.
1996: Michelotti A; Gennari A; Salvadori B; Giannessi P G; Baldini E; Tibaldi C; Da Prato M; Conte P F
Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
Seminars in oncology 1996;23(5 Suppl 11):38-40.
1996: Conte P F; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
Seminars in oncology 1996;23(5 Suppl 11):28-31.
1996: Tibaldi C; Baldini E; Ricci S; Conte P F
A pilot study with cisplatin, ifosfamide and weekly administration of vinorelbine as an outpatient combination chemotherapy for advanced non small cell lung cancer.
Anticancer research 1996;16(5B):3213-5.
1996: Baldini E; Tibaldi C; Chella A; Angeletti C A; Silvano G; Andrei A; Algeri R; Conte P F
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(7):747-9.
1996: Conte P F; Baldini E; Gardin G; Pronzato P; Amadori D; Carnino F; Monzeglio C; Gentilini P; Gallotti P; DeMicheli R; Venturini M; Rubagotti A; Rosso R
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):487-90.
1996: Collecchi P; Giannessi P G; Baldini E; Naccarato A G; Passoni A; Bevilacqua G; Conte P F
Effects of primary chemotherapy on biological parameters of locally advanced breast cancer.
Annals of the New York Academy of Sciences 1996;784():419-26.
1996: Conte P F; Michelotti A; Baldini E; Tibaldi C; DaPrato M; Salvadori B; Giannessi P G; Gentile A; Biadi O; Mariani M
Activity and safety of epirubicin plus paclitaxel in advanced breast cancer.
Seminars in oncology 1996;23(1 Suppl 1):28-32.
1995: Ardizzoni A; Addamo G F; Baldini E; Borghini U; Portalone L; De Marinis F; Lionetto R; Conte P F; Bruzzi P; Pennucci M C
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
British journal of cancer 1995;71(1):115-9.
1994: Baldini E; Giannessi P G; Gardin G; Alama A; Minuto F; Barreca A; Conte P F
In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma.
Journal of biological regulators and homeostatic agents 1994;8(4):113-6.
1994: Baldini E; Tibaldi C; Chella A; Angeletti C A; Romanini A; Andrei A; Algeri R; Silvano G; Conte P F
Combination chemotherapy with vinorelbine, ifosfamide, and cisplatin: a phase II study in stage IIIB-IV non-small cell lung cancer.
Seminars in oncology 1994;21(3 Suppl 4):12-5.
1994: Ardizzoni A; Bonavia M; Viale M; Baldini E; Mereu C; Verna A; Ferrini S; Cinquegrana A; Molinari S; Mariani G L
Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer.
Cancer 1994;73(5):1353-60.
1993: Baldini E; Gardin G; Naso C; Pronzato P; Rosso R; Rubagotti A; Monzeglio C; Brema F; Pastorino G; Amadori D
Stimulation of human breast cancer in vivo. Experimental findings and clinical results.
Annals of the New York Academy of Sciences 1993;698():418-22.
1992: Campora E; Pronzato P; Amoroso D; Bertelli G F; Venturini M; Baldini E; Brunetti I; Sertoli M R; Conte P; Rosso R
Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.
Anticancer research 1992;12(5):1555-8.
1991: Ardizzoni A; Rosso R; Salvati F; Scagliotti G; Soresi E; Ferrara G; Pennucci C; Baldini E; Cruciani A R; Antilli A
Combination chemotherapy and interferon alpha 2b in the treatment of advanced non-small-cell lung cancer. The Italian Lung Cancer Task Force (FONICAP).
American journal of clinical oncology 1991;14(2):120-3.
1991: Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Anticancer research 1991;11(2):681-4.
1990: Campora E; Baldini E; Rubagotti A; Chiara S; Bruzzi P; Sertoli M R; Rosso R
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
Journal of chemotherapy (Florence, Italy) 1990;2(5):336-9.
1990: Ardizzoni A; Sertoli M R; Corcione A; Pennucci M C; Baldini E; Intra E; Ferrarini M; Rosso R; Mazzanti P; Pistoia V
Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot study.
European journal of cancer (Oxford, England : 1990) 1990;26(9):937-41.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Editta Baldini

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Editta Baldini (preview)

All Publications